{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-033527","form_type":"8-K","ticker":"SRZN","cik":"0001824893","company_name":"Surrozen, Inc./DE","filed_at":"2023-07-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.504734+00:00","generated_at":"2026-06-13T06:30:00.006646+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Surrozen CSO Wen-Chen Yeh departs in restructuring; receives $337K severance, moves to advisory board","bullets":["CSO Wen-Chen Yeh to step down on July 31, 2023, as part of a planned restructuring and reduction-in-force.","Dr. Yeh will transition to the Scientific Advisory Board; existing equity awards continue vesting during advisory service.","Separation agreement provides $337,365 lump-sum severance (9 months salary) and COBRA premiums paid until April 30, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-033527","json":"https://secwatch.observer/filing/0000950170-23-033527.json","markdown":"https://secwatch.observer/filing/0000950170-23-033527.md","text":"https://secwatch.observer/filing/0000950170-23-033527.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1824893/000095017023033527/0000950170-23-033527-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1824893/000095017023033527/srzn-20230719.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T06:30:00.006646+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0cc412fb36","claim":"Wen-Chen Yeh resigned as Chief Scientific Officer at Surrozen, Inc./DE.","evidence_excerpt":"On July 14, 2023, Surrozen, Inc. and Wen-Chen Yeh, M.D., Ph.D., our Chief Scientific Officer, agreed that in connection with our planned restructuring and reduction-in-force, Dr. Yeh will cease serving as our Chief Scientific Officer and join our Scientific Advisory Board effective as of July 31, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1824893/000095017023033527/0000950170-23-033527-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Scientific Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}